SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
european biotech
An SI Board Since February 2000
Posts SubjectMarks Bans
108 13 0
Emcee:  dalroi Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
83Unique characteristics of PharmaMar's marine-derived drug hold promise for cnigel bates-4/10/2002
82MARTINSRIED/MUNICH, Germany and WALTHAM/BOSTON, Mass., March 21 /PRNewswire-Fistnigel bates-3/21/2002
81The European Commission has published details of a major policy initiative for tJMarcus-2/27/2002
80OGSI Vavesca is not a slam dunk. there have been some objections to OGSI's tSpekulatius-2/13/2002
79tuck: OGS now at $6.75 with some 'blocks' of adrs gone by is giving me keokalani'nui-2/13/2002
78Wilder, Indeed, but finally the U.S. biotechs got a little pop. Hoping the eurtuck-2/13/2002
77As of last week, European BTs were down only about 5% for the year with the US Bkeokalani'nui-2/12/2002
76<i>Anybody know why the european biotechs seem to be underperforming in thnigel bates-2/12/2002
75Anybody know why the european biotechs seem to be underperforming in the last fetuck-2/12/2002
74Thse are relevant to NicOx. Jason ===================================== Proc. Ntnsaf-2/10/2002
73HEALING PROCESS Cell-Based Cures Could Energize Biotech in Europe. Indeed, Europsmh-1/19/2002
72he you make fun with belgian co :-) thats not nice ! cheers Stefaandalroi-1/14/2002
71glamorous trade names! surprised that they didn't choose Anoplug....... Moscaram(o)uche-1/14/2002
70European investors appear to understand this arrangement better than many in theaknahow-1/14/2002
69From Independent Co U.K. Home > News > Business > Investment Column aknahow-1/14/2002
684SC and Wilex Sign Cancer Research Collaboration To Optimize Second Generation unigel bates-1/14/2002
67NEW YORK, Nov. 8 – GPC Biotech of Munich said Thursday it had agreed to build a nigel bates-11/9/2001
66ACADIA Nominates 5-HT2A Inverse Agonist for Clinical Development in Psychosis; Cnigel bates-10/30/2001
65Nice find. Thanks for sharing. Wilderkeokalani'nui-10/5/2001
64Recent piece on UK biotech worth a glance - itruffle.com nignigel bates-10/5/2001
63HUDDINGE, Sweden--(BUSINESS WIRE)--Sept. 3, 2001--Swedish biotechnology company,nigel bates-9/3/2001
62Karo Bio Announces the Ind Filing by Partner Bristol-Myers Squibb to Initiate Clnigel bates-8/31/2001
61STOCKHOLM, Sweden--(BUSINESS WIRE)--Aug. 30, 2001--A collaboration between Medivnigel bates-8/30/2001
60MARTINSRIED and MUNICH, Germany, and WALTHAM and BOSTON, Mass., Aug. 14/PRNewswinigel bates-8/14/2001
59I love the article. I hope the powers to be leverage the potential competitive ijayhawk969-7/18/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News